Panel Discussion: Drug Development During the COVID-19 Pandemic Part 2
Panel Discussion: Drug Development During the COVID-19 Pandemic Part 2
Home > News & Events > Panel Discussion: Drug Development During the COVID-19 Pandemic Part 2
Panel Discussion: Drug Development During the COVID-19 Pandemic Part 2
Webinar Date & Time: Tuesday, April 14, 2020 – 1:00pm EST
CMIC Groupwill be joining Nuventra Pharma Sciences‘ webinar on April 14th at 1:00pm EST for the second live panel discussion on drug development during the COVID-19 pandemic. The panel will have industry experts discuss the latest impacts on Phase 1 clinical trials and how labs are adjusting to the crisis.
Topics will include:
Regulatory impacts from a former FDA reviewer
The latest impact on ongoing and planned clinical trials from a Phase 1 site